Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Phase I Study of Tremelimumab Monotherapy or in Combination With Durvalumab in Japanese Patients With Advanced Solid Tumors or Malignant MesotheliomaThe oncologist (Dayton, Ohio), 2022-09, Vol.27 (9), p.e703-e722 [Peer Reviewed Journal]Published by Oxford University Press 2022. ;COPYRIGHT 2022 Oxford University Press ;Published by Oxford University Press 2022. 2022 The data published online to support this summary are the property of the authors. Please contact the authors about reuse rights of the original data. ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyac099 ;PMID: 35671201Full text available |
|
2 |
Material Type: Article
|
A Phase Ib Study of Safety and Pharmacokinetics of Ramucirumab in Combination With Paclitaxel in Patients With Advanced Gastric AdenocarcinomasThe oncologist (Dayton, Ohio), 2015-05, Vol.20 (5), p.493-494 [Peer Reviewed Journal]2015 AlphaMed Press ;AlphaMed Press; the data published online to support this summary is the property of the authors. ;AlphaMed Press; the data published online to support this summary is the property of the authors. 2015 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2014-0440 ;PMID: 25888272Full text available |
|
3 |
Material Type: Article
|
Multicenter Retrospective Study of 132 Patients with Unresectable Small Bowel Adenocarcinoma Treated with ChemotherapyThe oncologist (Dayton, Ohio), 2012-09, Vol.17 (9), p.1163-1170 [Peer Reviewed Journal]2012 AlphaMed Press ;AlphaMed Press 2012 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2012-0079 ;PMID: 22622149Full text available |
|
4 |
Material Type: Article
|
aCGH Analysis of Predictive Biomarkers for Response to Bevacizumab plus Oxaliplatin‐ or Irinotecan‐Based Chemotherapy in Patients with Metastatic Colorectal CancerThe oncologist (Dayton, Ohio), 2019-03, Vol.24 (3), p.327-337 [Peer Reviewed Journal]AlphaMed Press 2018 ;AlphaMed Press 2018. ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2018-0119 ;PMID: 30425180Full text available |